This activation ultimately leads to temozolomide resistance in glioblastoma.[39] CD44, a known cancer stem cell marker in various cancers,[40] and CCL2, a secreted protein, play pivotal roles in breast cancer metastasis and recurrence.[41] These 2 genes are key players in metastasis and recurrence of breast cancer. This evidence concerns the gene CCL2 and glioblastoma.